Project Objectives
The goal of neuromotor rehabilitation is to restore patient autonomy and upper-limb motor control. However, due to the severity and specificity of neurological injuries, recovery outcomes depend heavily on treatment quality, intensity, and the timely initiation of personalized rehabilitation protocols.
Today, therapy is predominantly delivered through conventional, therapist-led sessions. These approaches often lack sufficient intensity—patients remain inactive for up to 45% of therapy time due to fatigue—and provide limited objective measurement of functional progress. As a result, up to 45% of patients experience unresolved mobility impairments after rehabilitation, and only 10% achieve full recovery of motor function.
ALEx RS 1.0, a robotic exoskeleton for upper-limb neurorehabilitation, was developed to address these limitations and elevate rehabilitation effectiveness. With over 50 systems installed in clinical centers, ALEx RS has demonstrated strong clinical acceptance and validated the technological and therapeutic approach.
Building on this solid foundation, the development of ALEx RS 2.0 represents a strategic step forward to further enhance performance, usability, and scalability, while accelerating Wearable Robotics’ growth potential.
ALEx RS 2.0 is a bilateral robotic device designed for comprehensive upper-limb rehabilitation, integrating both motor and cognitive training components. The planned advancements include:
• An innovative modular hand module enabling full rehabilitation of shoulder, elbow, and hand
• Reduced system dimensions to allow multiple devices within the same clinical setting
• Enhanced aesthetics and ergonomics to improve comfort, usability, and patient engagement
